Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9396 USD | +0.01% | +5.57% | +309.41% |
03-21 | UpHealth, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-21 | UpHealth, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 323.1 | 24.54 | 4.245 | 17.52 | - |
Enterprise Value (EV) 1 | 323.1 | 24.54 | 4.245 | 17.52 | 17.52 |
P/E ratio | -0.7 x | -0.11 x | -0.07 x | 6.26 x | 2.47 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 2.61 x | 0.15 x | 0.03 x | 0.38 x | 0.35 x |
EV / Revenue | 2.61 x | 0.15 x | 0.03 x | 0.38 x | 0.35 x |
EV / EBITDA | -81 x | 7.54 x | 0.22 x | 1.83 x | 1.4 x |
EV / FCF | - | - | - | - | - |
FCF Yield | - | - | - | - | - |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 14,425 | 15,054 | 18,501 | 18,641 | - |
Reference price 2 | 22.40 | 1.630 | 0.2294 | 0.9396 | 0.9396 |
Announcement Date | 22-04-18 | 23-03-02 | 24-03-21 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net sales 1 | 123.8 | 158.8 | 130 | 46.4 | 49.65 |
EBITDA 1 | -3.99 | 3.256 | 19.56 | 9.565 | 12.54 |
EBIT 1 | -82.05 | -161.4 | -89.57 | 5.23 | 9.78 |
Operating Margin | -66.28% | -101.63% | -68.9% | 11.27% | 19.7% |
Earnings before Tax (EBT) 1 | -342.8 | -232.3 | -57.63 | 2.83 | 7.38 |
Net income 1 | -341 | -223 | -57.84 | 2.83 | 7.38 |
Net margin | -275.47% | -140.43% | -44.49% | 6.1% | 14.86% |
EPS 2 | -31.90 | -15.17 | -3.260 | 0.1500 | 0.3800 |
Free Cash Flow | - | - | - | - | - |
FCF margin | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 22-04-18 | 23-03-02 | 24-03-21 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 49.07 | 33.9 | 35.97 | 43.67 | 38.67 | 40.5 | 42.14 | 37.82 | 32.68 | 17.35 | 11 | 11.65 | 12 | 11.75 | 11.85 |
EBITDA 1 | 4.958 | -12.54 | -1.3 | 3.954 | -1.247 | 1.853 | 6.564 | 5.255 | 5.418 | 2.317 | 1.875 | 2.345 | 2.615 | 2.78 | 2.78 |
EBIT 1 | -2.854 | -39.02 | -17.91 | -10.04 | -120 | -13.41 | -0.778 | -10.74 | -72.79 | -5.263 | 0.6 | 1.04 | 1.78 | 1.81 | 1.81 |
Operating Margin | -5.82% | -115.09% | -49.79% | -23% | -310.43% | -33.11% | -1.85% | -28.4% | -222.73% | -30.34% | 5.45% | 8.93% | 14.83% | 15.4% | 15.27% |
Earnings before Tax (EBT) | 39.52 | -338.1 | -20 | -14.7 | -178.8 | -18.82 | -7.635 | -17.75 | -20.14 | -12.11 | - | 0.44 | 1.18 | 1.21 | 1.21 |
Net income | 32.59 | -336 | -17.44 | -12.44 | -165.8 | -27.36 | -8.083 | -19.13 | -20.6 | -10.02 | - | 0.44 | 1.18 | 1.21 | 1.21 |
Net margin | 66.42% | -991.15% | -48.5% | -28.48% | -428.7% | -67.55% | -19.18% | -50.57% | -63.05% | -57.78% | - | 3.78% | 9.83% | 10.3% | 10.21% |
EPS 2 | 2.800 | -23.60 | -1.200 | -0.9000 | -11.17 | -1.820 | -0.5100 | -1.050 | -1.120 | -0.5400 | -0.0800 | 0.005000 | 0.0300 | 0.0300 | 0.0600 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 21-11-10 | 22-04-18 | 22-05-23 | 22-08-15 | 22-12-29 | 23-03-02 | 23-05-11 | 23-08-10 | 23-11-20 | 24-03-21 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex | - | - | - | - | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 22-04-18 | 23-03-02 | 24-03-21 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+309.41% | 17.52M | |
-4.05% | 26.67B | |
+27.34% | 24.36B | |
+9.49% | 2.62B | |
+95.77% | 2.04B | |
-18.22% | 1.96B | |
+16.47% | 1.47B | |
-54.52% | 1.4B | |
+2.24% | 1.3B | |
-13.93% | 1.34B |
- Stock Market
- Equities
- UPHL Stock
- Financials UpHealth, Inc.